Part B of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
(1)
in the sixth column, expiration of approval, of row 60, spirotetramat, the date is replaced by ‘30 April 2024’;
(2)
in the sixth column, expiration of approval, of row 66, L-ascorbic acid, the date is replaced by ‘30 June 2024’;
(3)
in the sixth column, expiration of approval, of row 67, spinetoram, the date is replaced by ‘30 June 2024’;
(4)
in the sixth column, expiration of approval, of row 74, flubendiamide, the date is replaced by ‘31 August 2024’.